Phase II, Single-arm Study of FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of Colorectal Cancer Patients With Advanced Stage
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Fruquintinib (Primary) ; Sintilimab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Aug 2022 Status changed from not yet recruiting to recruiting.
- 17 Mar 2022 New trial record